Bill Wagner
Analyst · Stifel. Your line is open. Please go ahead
Thanks, Greg and thanks to everyone on the call for your time and interest in Caretrust. For the quarter, we recognized $14.8 million in rental revenue, up from $14.1 in Q4, due to investments closed in Q4 and Q1. For 2015, we expect to recognize $56 million from Ensign and $4.4 million new investments closed to-date for total rental revenue of $60.4 million. This is up from $600,000 from our prior call due to our recent 9.5% yielding $9.1 million investment, which closed on April 1. By the way, Ensign rents continue to be well covered on an EBITDAR basis at 1.94 times for the 12 months ending December 31, 2014, up from 1.91 times at September 30 and approximately 1.85 times since the spin. We continue to expect 2015 NOI from our three independent living facilities to be approximately $300,000 and interest income to be about $900,000. Interest expense was flat at $5.9 million for the quarter relative to the prior quarter and includes approximately $547,000 of amortization of deferred financing fees. We continue to expect interest expense to be approximately $24 million in 2015. G&A expense was down $800,000 from the fourth quarter, due to a bonus accrual made in Q4 offset by increased amortization of stock comp. You saw the release yesterday. You know that we updated our 2015 guidance to take into account our most recent $9.1 million investment. For 2015, we now expect approximately $63.9 million in total revenues exclusive of tenant reimbursements. Again, interest expense and G&A projections remain unchanged with approximately $24 million in projected interest expense, assuming no draws on our currently undrawn revolver and $6.2 million to $6.9 million in projected G&A. We are also projecting $0.98 to $1 in normalized FFO, $1.08 to $1.10 in normalized FAD and $0.28 to $0.30 of net income, all on a per share basis. These range are all up approximately $0.02 since our last call and these projections are based on diluted shares outstanding of approximately 31.6 million which you will recall increased in December by roughly 9 million due to the special dividend. No additional acquisitions or dispositions made beyond those today and exclusion of any future stock-based compensation. Turning now to the balance sheet. We ended the quarter with $13 million in cash, down from $25 million at year end, due to the 9.65% yielding $18 million investment that we made during the quarter and $4.0 million of dividends paid offset by cash flow from operations. The $0.16 quarterly dividend we declared in March equates on an annualized basis to approximately 59% payout ratio on the midpoint of our 2015 FAD guidance. We believe that this places Caretrust among the most conservative of our industry peers and provides meaningful assurances of our ability to pay a steady and growing dividend over time. Our remaining cash, as of today, is roughly $7 million, which with the $84 million currently available under our undrawn $150 million secured credit facility, gives us ample room to continue to grow. We can expand that $84 million by adding the investments closed over the past year to the line for an additional [indiscernible] in potential liquidity. And as noted in our press release yesterday regarding the recent exercise of a portion of our accordion, we have procured a commitment letter from the required majority of the lenders under our current credit facility to lend up to an additional $50 million a for total facility size of $200 million. The new commitment allows us to use the full $200 million under certain circumstances prior to collateralizing the draw with the properties acquired to be added to the line post-acquisition. We did this because in addition to the smaller deals that have been our bread and butter, we are actively pursuing investments that exceed our current availability. This commitment letter allows us to eliminate financing risk and strengthen our offers by making them noncontingent on financing which we believe will help us win more deals of size if we want to. And with that, I will turn it over to Mark and Dave to discuss the portfolio and the pipeline.